Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.
2.

A Social History of Disease: Contextualizing the Rise and Fall of Social Inequalities in Cause-Specific Mortality.

Clouston SA, Rubin MS, Phelan JC, Link BG.

Demography. 2016 Oct;53(5):1631-1656.

PMID:
27531503
3.

Surgical skills competitions at ACS chapter meetings can increase resident engagement.

Ardestani A, Sheu EG, Nepomnayshy D, Rubin MS, Buchmiller TL, Jaklitsch MT, Tavakkoli A.

Bull Am Coll Surg. 2016 May;101(5):44-5. No abstract available.

PMID:
27311235
4.

Perspectives on evolving dental care payment and delivery models.

Rubin MS, Edelstein BL.

J Am Dent Assoc. 2016 Jan;147(1):50-6. doi: 10.1016/j.adaj.2015.08.010. Epub 2015 Nov 6.

PMID:
26562730
5.

Basal View Reference Photographs for Nasolabial Appearance Rating in Unilateral Cleft Lip and Palate.

Rubin MS, Lowe KM, Clouston S, Shetye PR, Warren SM, Grayson BH.

J Craniofac Surg. 2015 Jul;26(5):1548-50. doi: 10.1097/SCS.0000000000001846.

PMID:
26163840
6.

Comparative Study of Early Secondary Nasal Revisions and Costs in Patients With Clefts Treated With and Without Nasoalveolar Molding.

Patel PA, Rubin MS, Clouston S, Lalezaradeh F, Brecht LE, Cutting CB, Shetye PR, Warren SM, Grayson BH.

J Craniofac Surg. 2015 Jun;26(4):1229-33. doi: 10.1097/SCS.0000000000001729.

PMID:
26080163
7.

Assessment of presurgical clefts and predicted surgical outcome in patients treated with and without nasoalveolar molding.

Rubin MS, Clouston S, Ahmed MM, M Lowe K, Shetye PR, Broder HL, Warren SM, Grayson BH.

J Craniofac Surg. 2015 Jan;26(1):71-5. doi: 10.1097/SCS.0000000000001233.

8.

Endogenous cell therapy improves bone healing.

Layliev J, Marchac A, Tanaka R, Szpalski C, Henderson R, Rubin MS, Saadeh PB, Warren SM.

J Craniofac Surg. 2015 Jan;26(1):300-5. doi: 10.1097/SCS.0000000000001306. Erratum in: J Craniofac Surg. 2015 Jul;26(5):e466. Szapalski, Caroline [corrected to Szpalski, Caroline].

PMID:
25502704
9.

Social inequalities in suicide: the role of selective serotonin reuptake inhibitors.

Clouston SA, Rubin MS, Colen CG, Link BG.

Am J Epidemiol. 2014 Oct 1;180(7):696-704. doi: 10.1093/aje/kwu191. Epub 2014 Aug 28.

PMID:
25167863
10.

A fundamental cause approach to the study of disparities in lung cancer and pancreatic cancer mortality in the United States.

Rubin MS, Clouston S, Link BG.

Soc Sci Med. 2014 Jan;100:54-61. doi: 10.1016/j.socscimed.2013.10.026. Epub 2013 Nov 1.

PMID:
24444839
11.

Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium.

Hauke RJ, Infante JR, Rubin MS, Shih KC, Arrowsmith ER, Hainsworth JD.

Melanoma Res. 2013 Dec;23(6):468-73. doi: 10.1097/CMR.0000000000000014.

PMID:
23969699
12.

Reply to M.-E. Percival et al and L.B. Saltz.

Hainsworth JD, Spigel DR, Rubin MS, Boccia RV, Greco FA.

J Clin Oncol. 2013 Jul 1;31(19):2514-5. No abstract available.

PMID:
23967489
13.

Pazopanib as second-line treatment after sunitinib or bevacizumab in patients with advanced renal cell carcinoma: a Sarah Cannon Oncology Research Consortium Phase II Trial.

Hainsworth JD, Rubin MS, Arrowsmith ER, Khatcheressian J, Crane EJ, Franco LA.

Clin Genitourin Cancer. 2013 Sep;11(3):270-5. doi: 10.1016/j.clgc.2013.04.006. Epub 2013 May 9.

PMID:
23665131
14.

Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.

Infante JR, Arkenau HT, Bendell JC, Rubin MS, Waterhouse D, Jones GT, Spigel DR, Lane CM, Hainsworth JD, Burris HA 3rd.

Cancer Biol Ther. 2013 Apr;14(4):340-6. doi: 10.4161/cbt.23625. Epub 2013 Jan 28.

15.

The dynamic relationship between physical function and cognition in longitudinal aging cohorts.

Clouston SA, Brewster P, Kuh D, Richards M, Cooper R, Hardy R, Rubin MS, Hofer SM.

Epidemiol Rev. 2013;35:33-50. doi: 10.1093/epirev/mxs004. Epub 2013 Jan 24. Review.

16.

Fundamental causes of colorectal cancer mortality in the United States: understanding the importance of socioeconomic status in creating inequality in mortality.

Saldana-Ruiz N, Clouston SA, Rubin MS, Colen CG, Link BG.

Am J Public Health. 2013 Jan;103(1):99-104. doi: 10.2105/AJPH.2012.300743. Epub 2012 Nov 15.

17.

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Hainsworth JD, Rubin MS, Spigel DR, Boccia RV, Raby S, Quinn R, Greco FA.

J Clin Oncol. 2013 Jan 10;31(2):217-23. doi: 10.1200/JCO.2012.43.3755. Epub 2012 Oct 1.

PMID:
23032625
18.

Fundamental causes of colorectal cancer mortality: the implications of informational diffusion.

Wang A, Clouston SA, Rubin MS, Colen CG, Link BG.

Milbank Q. 2012 Sep;90(3):592-618. doi: 10.1111/j.1468-0009.2012.00675.x.

19.

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.

Spigel DR, Greco FA, Rubin MS, Shipley D, Thompson DS, Lubiner ET, Eakle JF, Quinn R, Burris HA, Hainsworth JD.

Lung Cancer. 2012 Aug;77(2):359-64. doi: 10.1016/j.lungcan.2012.03.009. Epub 2012 May 3.

PMID:
22560921
20.

Parameters of care for craniosynostosis: dental and orthodontic perspectives.

Vargervik K, Rubin MS, Grayson BH, Figueroa AA, Kreiborg S, Shirley JC, Simmons KE, Warren SM.

Am J Orthod Dentofacial Orthop. 2012 Apr;141(4 Suppl):S68-73. doi: 10.1016/j.ajodo.2011.12.013.

PMID:
22449601

Supplemental Content

Loading ...
Support Center